Combining phased and linear arrays on a single head, the Clarius PAL HD3 ultrasound device was unveiled at the recent American College of Emergency Physicians (ACEP) Scientific Assembly conference.
Featuring the imaging processing technology of traditional ultrasound systems, the newly launched Clarius PAL HD3 handheld ultrasound device reportedly offers an array of features to facilitate real-time, whole-body imaging at a patient’s bedside.
Showcased at the recent American College of Emergency Physicians (ACEP) Scientific Assembly in Philadelphia, the FDA-cleared ultrasound device provides high-resolution images from superficial anatomy down to 40 cm of depth, according to Clarius.
The company said other key features of the Clarius PAL HD3 device include advanced eight beamformer image processing technology (in comparison to one or two beamformer processing for the majority of other handheld ultrasound devices), and easy access to phased and linear arrays on a single head.
"The Clarius PAL is a big breakthrough for Clarius and for clinical ultrasound in general. Integrating the phased and linear array means you only need one transducer for 95 to 99% of the studies at the bedside," said Tom Cook, M.D., an emergency physician, and ultrasound educator who practices in Columbia, South Carolina.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.